Stödberg, T; McTague, A; Ruiz, AJ; Hirata, H; Zhen, J; Long, P; Farabella, I; ... Kurian, MA; + view all Stödberg, T; McTague, A; Ruiz, AJ; Hirata, H; Zhen, J; Long, P; Farabella, I; Meyer, E; Kawahara, A; Vassallo, G; Stivaros, SM; Bjursell, MK; Stranneheim, H; Tigerschiöld, S; Persson, B; Bangash, I; Das, K; Hughes, D; Lesko, N; Lundeberg, J; Scott, RC; Poduri, A; Scheffer, IE; Smith, H; Gissen, P; Schorge, S; Reith, ME; Topf, M; Kullmann, DM; Harvey, RJ; Wedell, A; Kurian, MA; - view fewer (2015) Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures. Nature Communications , 6 p. 8038. 10.1038/ncomms9038.

Preview	Text 44935_2_supp_1211265_npst2y_convrt.pdf Download (1MB) | Preview
Preview	Text Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures..pdf Download (2MB) | Preview

Abstract

The potassium-chloride co-transporter KCC2, encoded by SLC12A5, plays a fundamental role in fast synaptic inhibition by maintaining a hyperpolarizing gradient for chloride ions. KCC2 dysfunction has been implicated in human epilepsy, but to date, no monogenic KCC2-related epilepsy disorders have been described. Here we show recessive loss-of-function SLC12A5 mutations in patients with a severe infantile-onset pharmacoresistant epilepsy syndrome, epilepsy of infancy with migrating focal seizures (EIMFS). Decreased KCC2 surface expression, reduced protein glycosylation and impaired chloride extrusion contribute to loss of KCC2 activity, thereby impairing normal synaptic inhibition and promoting neuronal excitability in this early-onset epileptic encephalopathy.

Download activity - last month

Export as XMLJSONCSV

Download activity - last 12 months

Export as JSONCSVXML

Downloads by country - last 12 months

Export as CSVJSONXML

Archive Staff Only

View Item